Home

JOHN A KANE

CIK 1049356 · Interim CFO · last filed 2025-07-10

JOHN A KANE is an Interim CFO who has filed 43 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing, for HCAT, was dated Jul 10, 2025. Across all open-market trades the lifetime net is −$7.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $293.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$293.6K

Companies

3

Total Filings

43

Lifetime Open-Market Net

-$7.59M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HCAT Director 170,719 $1.72 $293.6K $0 8 2025-07-10
ATHENAHEALTH INC (ATHN) Delisted Interim CFO 13,940 $9.59 $133.7K -$7.69M 28 2018-06-08
MERCHANTS BANCSHARES INC (MBVT) Delisted Director 3,654 — — $107.6K 6 2013-04-29

Recent Filings

43 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-07-10 HCAT Grant (A) +36,231 $0 EDGAR
2024-06-17 HCAT Grant (A) +20,807 $0 EDGAR
2023-06-16 HCAT Grant (A) +22,553 $0 EDGAR
2022-06-16 HCAT Grant (A) +11,677 $0 EDGAR
2021-06-14 HCAT Grant (A) +3,285 $0 EDGAR
2020-06-17 HCAT Grant (A) +5,443 $0 EDGAR
2019-09-03 HCAT Grant (A) +3,557 $0 EDGAR
2019-07-29 HCAT Conv (C) +24,175 $0 EDGAR
2019-02-13 — Disp (D) −13,940 -$1.88M
2018-06-08 ATHENAHEALTH INC (ATHN) Delisted Grant (A) +1,931 $0 EDGAR
Showing 1–10 of 43
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.